Live feed08:36:57·1hANALYSTRatingvia QuantisnowRoth Capital initiated coverage on Castle Biosciences with a new price targetByQuantisnow·Wall Street's wire, on your screen.CSTL· Castle Biosciences Inc.Health CareOriginal source